This present study sets out to unravel the effect of combined oral contraceptives (COCs) on specific elements of MetS and the possible benefits of intranasal insulin (INI), metformin (MET), and saxagliptin (SAX) in various combination regimens in the management of this syndrome. The gene discussed is INS; the disease is metabolic syndrome.